Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept-Reference-Cited by-同舟云学术

Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept

Published:2010-07-22 Issue:4 Volume:163 Page:838-846
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Van Lümig P.P.M.,Lecluse L.L.A.,Driessen R.J.B.,Spuls P.I.,Boezeman J.B.,Van De Kerkhof P.C.M.,De Jong E.M.G.J.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2010.09950.x/fullpdf

Reference26 articles.

1. Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience;Coates;Ann Rheum Dis,2008

2. Infliximab in the treatment of psoriasis in patients previously treated with etanercept;Haitz;J Am Acad Dermatol,2007

3. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics;Papoutsaki;J Am Acad Dermatol,2007

4. Efficacy of etanercept in psoriatic patients previously treated with infliximab;Pitarch;Dermatology,2008

5. Adalimumab treatment for severe recalcitrant chronic plaque psoriasis;Ryan;Clin Exp Dermatol,2009

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry;Dermatology and Therapy;2022-11-04

2. Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks;International Journal of Environmental Research and Public Health;2022-06-02

3. [Translated article] Practical Update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis with Biologic Therapy. Part 1. Concepts and General Management of Psoriasis With Biologic Therapy;Actas Dermo-Sifiliográficas;2022-03

4. TNF-Alpha Class of Biologic Agents in Psoriatic Disease;Updates in Clinical Dermatology;2022

5. Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 1. «Conceptos y manejo general de la psoriasis con terapia biológica»;Actas Dermo-Sifiliográficas;2021-10